Management of Sodium 125 mmol/L in Liver Cirrhosis
For a cirrhotic patient with serum sodium of 125 mmol/L, you should stop diuretics and observe the patient closely, with the decision to initiate volume expansion guided by renal function status. 1, 2
Algorithmic Approach Based on Renal Function
Your management hinges on two critical parameters: serum sodium (125 mmol/L falls in the moderate hyponatremia range of 121-125 mmol/L) and renal function status.
If Serum Creatinine is Normal:
- Stop diuretics immediately 1
- Observe the patient without active correction
- Monitor electrolytes closely
- Do NOT restrict water at this sodium level with normal renal function 1
The 2006 Gut guidelines acknowledge controversy here: while international consensus suggests continuing diuretics, the guideline authors advocate for a more cautious approach of stopping diuretics once sodium drops below 125 mmol/L 1. This conservative strategy prioritizes avoiding further decline in renal function over maintaining diuresis.
If Serum Creatinine is Elevated (>150 mmol/L or >120 mmol/L and rising):
- Stop diuretics immediately
- Initiate volume expansion with colloid (haemaccel, gelofusine, voluven) or normal saline 1
- Accept that this will worsen ascites—the priority is preventing irreversible renal failure
- The rationale: "better to have ascites with normal renal function than to develop potentially irreversible renal failure" 1
Correction Rate: Critical Safety Parameter
If correction is undertaken, never increase sodium by >12 mmol/L per 24 hours 1. The more recent 2021 AASLD guidance is even more conservative, recommending 4-6 mEq/L per 24 hours, not exceeding 8 mEq/L per 24 hours 3. This is essential to prevent osmotic demyelination syndrome (ODS), particularly in patients awaiting liver transplantation 1, 3.
When to Consider Fluid Restriction
Fluid restriction (1-1.5 L/day) should be reserved ONLY for patients who are clinically hypervolemic with severe hyponatremia (<125 mmol/L), not currently taking diuretics, and with normal serum creatinine 1, 2, 4.
The 2021 Gut guidelines specifically state that fluid restriction should be used for those "clinically hypervolemic with severe hyponatremia (serum sodium <125 mmol/L)" 2. This represents an evolution from the traditional approach, as water restriction may paradoxically worsen the underlying pathophysiology by exacerbating effective central hypovolemia, driving further ADH secretion and worsening renal function 1.
Special Considerations
Hypertonic Saline
Reserved exclusively for:
- Severely symptomatic patients (seizures, coma, cardiorespiratory distress) 5, 3
- Patients with imminent liver transplantation 3
- This is NOT indicated for asymptomatic hyponatremia at 125 mmol/L
Vaptans (Vasopressin Receptor Antagonists)
While effective at raising sodium, they should be used with extreme caution and only short-term (≤30 days) 3. Long-term use with satavaptan showed increased all-cause mortality 5, making them unsuitable for routine management.
Albumin Infusion
Can be considered in patients with elevated creatinine or acute kidney injury 2, 4, 3, though evidence quality is low. The 2025 AGA guidance suggests albumin based on volume assessment in severe cases 4.
Common Pitfalls to Avoid
- Do not reflexively restrict water at sodium 125 mmol/L—this may worsen the underlying pathophysiology 1
- Do not continue diuretics hoping sodium will stabilize—at 125 mmol/L, the risk outweighs benefit 1
- Do not aggressively correct with hypertonic saline unless severely symptomatic—ODS risk is substantial 5, 3
- Do not ignore renal function—this determines whether observation alone suffices or volume expansion is needed 1
The evidence consistently shows that hyponatremia at this level signals advanced disease with poor prognosis 6, 7, 8, making prevention of further complications (particularly renal failure and ODS) the primary therapeutic goal rather than aggressive sodium correction.